We can analyze the diversity and frequency of T-cell receptors to help identify and validate novel therapeutic targets and biomarkers for immunotherapy.
Learn More →Cancer epitope analysis is the research that determines the specific cancer peptides that directly bind to cell receptors or antibodies and elicit immune responses. Creative Biolabs provides advanced and standard X-ray crystallography assays for the inspection of specific interactions between tumor antigen epitopes and immune cell receptors and antibodies.
Protein antigen epitopes are classified into two kinds: linear and conformational epitopes. Linear epitopes consist of several continuous amino acid sequences, and conformational epitopes are not only amino acid sequences but also associated with the 3D structure of these peptides. In T cell immunity, the T cell receptor is responsible for the recognition of HLA-restricted antigen peptides, but most TCRs bind sub-optimally to tumor antigens. Moreover, most epitopes directly in contact with antibodies are complex, discontinuous conformational epitopes and thus should be screened by structural methods.
Discover how we can help - Request a consultation.
Fig.1 Main steps for protein structure determination using X-ray crystallography.1
| Key Features of X-ray Crystallography Assay | Antibody Format Can Be Used |
|---|---|
|
Any antibody format can be used for corresponding epitope analysis, including:
|
Our assay provides high-resolution visualization of interactions between antigens and immune cell receptors. This enables the detailed inspection of complex conformational epitopes and the precise identification of an interaction domain.
We facilitate the co-crystallization of antibody-antigen complexes and determine conformational epitopes for various receptors. This includes all antibody formats, such as Fabs, scFvs, and sdAbs, for comprehensive analysis.
The atomic-resolution data from our assay serve as a blueprint for rational drug design. This insight allows you to optimize lead molecules, enhance binding affinity, and accelerate your therapeutic development pipeline.
Our established platform and expertise ensure the production of high-quality, publication-ready data. This data is critical for supporting your research, patent filings, and regulatory submissions.
Discover how a partnership with us can streamline your research - Get a quote today.
We have extensive experience with challenging proteins. Our high-throughput screening platform and expert optimization strategies are designed to overcome typical crystallization hurdles. We also offer tailored solutions for complex proteins, ensuring the best chance of success.
Getting started is simple! We'll need information about your target protein, your lead compound, and your project goals. We can also assist with protein production if you do not have a purified protein ready. To begin, simply reach out to our team to discuss your project requirements.
We can analyze the diversity and frequency of T-cell receptors to help identify and validate novel therapeutic targets and biomarkers for immunotherapy.
Learn More →We assess the ability of tumor-specific neoantigens to elicit a potent T-cell response, a critical step in developing personalized cancer vaccines and adoptive cell therapies.
Learn More →Creative Biolabs possesses a leading technique in protein structure analysis and focuses on cancer epitope-receptor interactions using X-ray structure determination for years. Creative Biolabs works closely with our clients to provide tailored strategies for the structure and interaction determination, and provides detailed and accurate data and information on the complex. No more looking around, and contact us for a detailed quote.
Reference